论文部分内容阅读
目的 :评价中晚期非小细胞肺癌的治疗方法及疗效。方法 :68例经病理学证实为肺癌患者 ,2 0例行放射治疗 (放疗组 ) ,原发灶DT60— 70GY/6— 8周 ,48例放疗后 (剂量同前 )再行CAP或MVP方案化疗。结果 :放疗组、综合组肿块消退 (CR +PR)分别为 5 0 %、 70 7% (P <0 0 5 ) ;1、 2、 3年生存率分别为5 5 %、 3 5 %、 1 0 %及 79%、 62 5 %、 3 5 % (P <0 0 5 )。结论 :综合治疗较单纯放射治疗效果优越 ,对中晚期非小细胞肺癌患者 ,宜综合治疗
Objective: To evaluate the treatment and efficacy of advanced non-small cell lung cancer. Methods: 68 cases of lung cancer patients confirmed by pathology, 20 cases of radiation therapy (radiotherapy group), primary tumor DT60-70GY/6-8 weeks, 48 cases of radiography or MVP after radiotherapy (dose same as before) Chemotherapy. Results: The tumor regression (CR + PR) in the radiotherapy group and the comprehensive group was 50% and 707% (P <0 05), respectively; the 1-, 2-, and 3-year survival rates were 55%, 35%, and 1 respectively. 0 % and 79%, 62 5 %, 35 % (P <0 0 5). Conclusion :Comprehensive treatment is superior to radiotherapy alone. It is recommended to treat patients with advanced non-small cell lung cancer.